3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
5
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
24
Carcinoma, Non-Small-Cell Lung
15
Colorectal Neoplasms
13
Lung Neoplasms
12
Neoplasms
11
Stomach Neoplasms
9
Neoplasm Metastasis
6
Colonic Neoplasms
6
Esophageal Neoplasms
5
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Ovarian Neoplasms
3
Osteosarcoma
3
Multiple Myeloma
3
Melanoma
3
Lymphoma, Follicular
3
Lymphoma
3
Waldenstrom Macroglobulinemia
2
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Rectal Neoplasms
2
Interventions
Liquid Biopsy
4
Blood Specimen Collection
4
Gemcitabine
3
pembrolizumab
2
Immunohistochemistry
2
Cisplatin
2
Capecitabine
2
Base Sequence
2
130-nm albumin-bound paclitaxel
2
tislelizumab
1
taxane
1
lenvatinib
1
irinotecan sucrosofate
1
gemcitabine-oxaliplatin regimen
1
Tegafur
1
Taxes
1
Surgical Procedures, Operative
1
Standard of Care
1
S 1 (combination)
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Oxaliplatin
1
Nivolumab
1
Microscopy, Confocal
1
Methylation
1
Mass Spectrometry
1
Leucovorin
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
High-Throughput Nucleotide Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Biliary Tract Neoplasms
×
Drug Therapy
×
Clear all
NCT06975917
2025-05-16
TOG-SAFRADJU
Ankara University
Active not recruiting
600 enrolled